StrokeNCT03832413
Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders
An observational study of Stroke and TBI, run by QuantalX Neuroscience at 1 site in Israel.
Trial summary
We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Stroke, TBI, Fibromyalgia
- What is being tested?
- DELPhI (TMS-EEG analysis)
- How many people
- 193 participants
- Where
- 1 siteIsrael
- Study dates
- 23 Apr 2018to 14 Feb 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Patients arriving to the Sagol center for Hyperbaric medicine at Assaf harofe Medical center, undergoing a series of hyperbaric treatment sessions and will be found compatible to inclusion/exclusion criteria.
Who may be able to join
- Man and woman at the ages of ≥18 years.
- Designated to perform a neurocognitive evaluation at the Sagol center for hyperbaric medicine and research, at Assaf-Harofe Medical center.
Who cannot join
- Under 18 years of age.
- With a skin condition on the scalp preventing the placement of EEG cap.
- Pregnant or breastfeeding woman.
- Unable to give an informed consent.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders-A Pilot Study
We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. EEG provides an opportunity to directly measure the cerebral response to TMS, measuring the cortical TMS Evoked potential (TEP). In this study we measure TEPs, in a wide variety of neurological conditions and healthy as a measure of cerebral reactivity across wide areas of neocortex.
Read the detailed description
Brain network plasticity evaluation has been shown extensively essential for understanding and monitoring of brain functional changes and brain disorders. However, existing clinically used imaging methods are unable to robustly indicate plasticity or plasticity changes. Therefore, there is a great need for developing such an imaging tool for brain functional evaluation. In basic neuroscience research plasticity evaluation is performed by conducting electrophysiological measurements in vivo. By using EEG - combined with TMS stimulation this methodology can be transformed into clinically used plasticity and connectivity assessment for evaluation of functional brain status. This study may thus introduce a novel, non-invasive and efficient method for brain functional imaging. DELPhI evaluation will offer a true multimodality imaging by combining EEG and TMS that allows a quantative objective and direct identification of disease assessment. There is a real unmet need for an accurate and objective evaluation that together with the common clinical practice will provide neurologists and psychiatrists a more definite and personalized treatment prescription.
Studies integrating TMS with EEG (TMS-EEG) have shown that TMS produces waves of activity that reverberate throughout the cortex and that are reproducible and reliable thus providing direct information about cortical excitability and connectivity with excellent time resolution. By evaluating the propagation of evoked activity in different behavioral states and in different tasks, TMS-EEG has been used to causally probe the dynamic effective connectivity of human brain networks. When applying the TMS coil above the motor cortex, a cascade effect called the motor-evoked potential (MEP), is initiated. The MEP is measurable at peripheral muscles. The Motor cortex is a brain structure located between the frontal and parietal cortices. Pyramidal neurons in the motor cortex, upper motor neuron going through the brain stem, send signals to lower motor neuron in the spinal cord which stimulate muscle fibers. TMS stimulus to the Motor cortex evokes a brain response which propagates to different brain regions in addition to the peripheral limb muscles [20]. An important feature of TEP topography is that even though only one cortical hemisphere is stimulated, bihemispheric EEG evoked responses are evoked with different features. TMS-evoked activity propagates from the stimulation site ipsilaterally via association fibers and contralaterally via transcallosal fibers and to subcortical structures via projection fibers. These TMS-evoked cortical potentials (TEPs) last for up to 300 ms in both the vicinity of the stimulation as well as in remote interconnected brain areas reflect long term changes in cortical network excitation-inhibition balance refeed to as brain network plasticity. A single TMS pulse delivered over the primary motor cortex (M1) results in a sequence of positive and negative EEG peaks at specific latencies (i.e., P25, N45, P70, N100, and P180).
In this study a wide population of subjects will be recruited. this population will include different neurological conditions and healthy subjects, arriving to the Hyperbaric center at Asaf-Harophe hospital. Each subject will be tested once before treatment initiation and subsequent tests will be performed also after treatment termination or at follow up time points. Each evaluation will last up to 90 minutes and will include affixed stimulation protocol ranging Up to 1000 TMS pulses, with intensities between 60-130% of motor threshold (MT). Inter-stimuli frequency will change from 0.01 up to 20 Hz.Existing clinical data such as MRI scans, neurocognitive assessments and clinical evaluations will be collected out of patient files. EEG data recorded will be analyzed and corrolations to the clinical data will be tested.
- Being tested
- DELPhI (TMS-EEG analysis)
- Medical subject headings
- Stroke, Fibromyalgia, Attention Deficit Disorder with Hyperactivity, Stress Disorders, Post-Traumatic, Dementia, Cognitive Dysfunction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
DELPhI (TMS-EEG analysis)Diagnostic test
We perform an evaluation not an intervention. the DELPhI evaluation comprises of an automated analysis to EEG data recorded during TMS (Transcranial Magnetic Stimulation) to the M1L (Primary motor cortex).
| Study group | Role | What they receive |
|---|---|---|
| Stroke | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| TBI | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| ABD | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| Fibromyalgia | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| PDD | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| ADHD | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| MCI | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| Dementia | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| Healthy | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) | |
| Cognitive impairment | Diagnostic Test: DELPhI (TMS-EEG analysis) Receives: Diagnostic Test: DELPhI (TMS-EEG analysis) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Correlation between DELPhI's parameters to MRI scans
Correlation between DELPhI parameters to cognitive assessment by MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).
Measured: through study completion, an average of 1 year
Correlation between DELPhI's parameters to cognitive assessment
Correlation between DELPhI parameters to MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).
Measured: through study completion, an average of 1 year
Secondary outcomes (1)
Cluster TMS Evoked Responses' (TEPs') features such as amplitude, latency, Area under the curve and slopes.
Calculating potential clusters based on TEP's features at different stimulation conditions. Features such as amplitude, area under the curve, slope and latency.
Measured: through study completion, an average of 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Feb 2019
- Study start23 Apr 2018
- Primary completion14 Feb 2022
- Study completion14 Feb 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for StrokeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 193 participants (actual)
Sponsor and investigators
- Lead sponsor
- QuantalX Neuroscience
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03832413
- Sponsor's protocol ID
- QuantalX_pilot_asaf_harophe
- Status last verified
- Feb 2019
- First submitted
- 1 Nov 2018
- Last updated
- 16 Feb 2022
- Results posted
- No
- FDA-regulated device
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 16 Feb 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Characterization of the DELPhI System in Assessing Brain's Functionality in Different Neurological Disorders-A Pilot Study
- ClinicalTrials.gov ID
- NCT03832413
- Acronym / sponsor ID
- QuantalX_pilot_asaf_harophe
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 193 participants (actual)
- Lead sponsor
- QuantalX NeuroscienceIndustry (pharma, biotech, devices)
- Study start
- 23 Apr 2018 (actual)
- Primary completion
- 14 Feb 2022 (actual)
- Study completion
- 14 Feb 2022 (actual)
- First posted
- 6 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
We use Transcranial magnetic stimulation (TMS), combined with simultaneous registration of electroencephalograph (EEG),for examining human cortical functionality. TMS-EEG is a noninvasive brain stimulation method that allows to study human cortical function in vivo. EEG provides an opportunity to directly measure the cerebral response to TMS, measuring the cortical TMS Evoked potential (TEP). In this study we measure TEPs, in a wide variety of neurological conditions and healthy as a measure of cerebral reactivity across wide areas of neocortex.
Detailed description
Brain network plasticity evaluation has been shown extensively essential for understanding and monitoring of brain functional changes and brain disorders. However, existing clinically used imaging methods are unable to robustly indicate plasticity or plasticity changes. Therefore, there is a great need for developing such an imaging tool for brain functional evaluation. In basic neuroscience research plasticity evaluation is performed by conducting electrophysiological measurements in vivo. By using EEG - combined with TMS stimulation this methodology can be transformed into clinically used plasticity and connectivity assessment for evaluation of functional brain status. This study may thus introduce a novel, non-invasive and efficient method for brain functional imaging. DELPhI evaluation will offer a true multimodality imaging by combining EEG and TMS that allows a quantative objective and direct identification of disease assessment. There is a real unmet need for an accurate and objective evaluation that together with the common clinical practice will provide neurologists and psychiatrists a more definite and personalized treatment prescription.
Studies integrating TMS with EEG (TMS-EEG) have shown that TMS produces waves of activity that reverberate throughout the cortex and that are reproducible and reliable thus providing direct information about cortical excitability and connectivity with excellent time resolution. By evaluating the propagation of evoked activity in different behavioral states and in different tasks, TMS-EEG has been used to causally probe the dynamic effective connectivity of human brain networks. When applying the TMS coil above the motor cortex, a cascade effect called the motor-evoked potential (MEP), is initiated. The MEP is measurable at peripheral muscles. The Motor cortex is a brain structure located between the frontal and parietal cortices. Pyramidal neurons in the motor cortex, upper motor neuron going through the brain stem, send signals to lower motor neuron in the spinal cord which stimulate muscle fibers. TMS stimulus to the Motor cortex evokes a brain response which propagates to different brain regions in addition to the peripheral limb muscles [20]. An important feature of TEP topography is that even though only one cortical hemisphere is stimulated, bihemispheric EEG evoked responses are evoked with different features. TMS-evoked activity propagates from the stimulation site ipsilaterally via association fibers and contralaterally via transcallosal fibers and to subcortical structures via projection fibers. These TMS-evoked cortical potentials (TEPs) last for up to 300 ms in both the vicinity of the stimulation as well as in remote interconnected brain areas reflect long term changes in cortical network excitation-inhibition balance refeed to as brain network plasticity. A single TMS pulse delivered over the primary motor cortex (M1) results in a sequence of positive and negative EEG peaks at specific latencies (i.e., P25, N45, P70, N100, and P180).
In this study a wide population of subjects will be recruited. this population will include different neurological conditions and healthy subjects, arriving to the Hyperbaric center at Asaf-Harophe hospital. Each subject will be tested once before treatment initiation and subsequent tests will be performed also after treatment termination or at follow up time points. Each evaluation will last up to 90 minutes and will include affixed stimulation protocol ranging Up to 1000 TMS pulses, with intensities between 60-130% of motor threshold (MT). Inter-stimuli frequency will change from 0.01 up to 20 Hz.Existing clinical data such as MRI scans, neurocognitive assessments and clinical evaluations will be collected out of patient files. EEG data recorded will be analyzed and corrolations to the clinical data will be tested.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 10
| Arm | Type | Receives |
|---|---|---|
| Stroke | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| TBI | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| ABD | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| Fibromyalgia | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| PDD | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| ADHD | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| MCI | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| Dementia | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| Healthy | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
| Cognitive impairment | – | Diagnostic Test: DELPhI (TMS-EEG analysis)Diagnostic Test: DELPhI (TMS-EEG analysis) |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Patients arriving to the Sagol center for Hyperbaric medicine at Assaf harofe Medical center, undergoing a series of hyperbaric treatment sessions and will be found compatible to inclusion/exclusion criteria.
Key inclusion criteria (2 listed)
- Man and woman at the ages of ≥18 years.
- Designated to perform a neurocognitive evaluation at the Sagol center for hyperbaric medicine and research, at Assaf-Harofe Medical center.
Key exclusion criteria (4 listed)
- Under 18 years of age.
- With a skin condition on the scalp preventing the placement of EEG cap.
- Pregnant or breastfeeding woman.
- Unable to give an informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| DELPhI (TMS-EEG analysis)We perform an evaluation not an intervention. the DELPhI evaluation comprises of an automated analysis to EEG data recorded during TMS (Transcranial Magnetic Stimulation) to the M1L (Primary motor cortex). | Diagnostic test | ABD, ADHD, Cognitive impairment, Dementia, Fibromyalgia, Healthy, MCI, PDD, Stroke, TBI |
Primary outcome
Correlation between DELPhI's parameters to MRI scans
Time frame: through study completion, an average of 1 year
Correlation between DELPhI parameters to cognitive assessment by MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).
Correlation between DELPhI's parameters to cognitive assessment
Time frame: through study completion, an average of 1 year
Correlation between DELPhI parameters to MRI/CT and computerized cognitive evaluation (Mindstreems cognitive battery test).
1 secondary outcome
Cluster TMS Evoked Responses' (TEPs') features such as amplitude, latency, Area under the curve and slopes.
Time frame: through study completion, an average of 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Feb 2022.
Related trials for Stroke
Recruiting
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Stroke, Acute
RecruitingPhase 4
Xeomin® and Gait Related Mobility After Stroke
Stroke
RecruitingObservational study
Implementing Transcranial Direct Current Stimulation in a Rehabilitation Setting
Aphasia, Stroke
Not yet recruiting
EEG Feedback-Based Vagus Nerve Stimulation for Post-Stroke Dysphagia
Ischemic Stroke, Post-stroke Dysphagia
RecruitingObservational study
Development and Validation of Risk Prediction Models for Stroke and Cognitive Impairment in Moyamoya Disease and Moyamoya Syndrome
Moyamoya Disease, Moyamoya Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Stroke and TBI, run by QuantalX Neuroscience at 1 site in Israel.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 16 Feb 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Israel. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Correlation between DELPhI's parameters to MRI scans (time frame: through study completion, an average of 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2022.